Nokxaban

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNokxaban
Drug Alias NameLCB-02-0133GC-4401CB02-0133GCC-4401CGC-2107 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsThromboembolismStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLegochem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLee'S Pharmaceutical (Hk) LtdLegochemGC Biopharma Corp
Active IndicationsN/A
Inactive IndicationsThromboembolismStroke

Other Information

ATC CodeN/A
Related LinksN/A